AzTrials
AzTrials

SepsisCRESTNCT01426711

Critical Care Excellence in Sepsis and Trauma

An observational study of Sepsis and Trauma, run by Medical University of South Carolina at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The care of patients with sepsis and trauma requires the delivery of appropriate definitive care in the early stages of the illness. Hospitals with limited resources, those in rural and underserved areas of South Carolina, may be unable to consistently provide optimal care to these patients. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sepsis, Trauma
How many people
26 participants
Where
5 sitesUnited States
Study dates
Sep 2009to Mar 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population is adult patients presenting to rural community hospital's emergency departments wth possible sepsis or severe sepsis and/or blunt or penetrating trauma.

Who may be able to join

  • Sepsis study patients are adult patients presenting to the rural hospital's EDs that meet the screening criteria for sepsis and two of four SIRS criteria.
  • The screening criteria for possible sepsis are:
  • known or suspected infection AND EITHER
  • systolic blood pressure < 90mmHg after fluid challenge of 30mL/kg over 30 minutes OR
  • lactate > 4mmol/L
  • The screening criteria for possible SIRS are:
Show all 29Show fewer
  • abnormal core body temperature (<36.5 C or > 38 C)
  • heart rate > 90 bpm
  • respiratory insufficiency (respiratory rate > 20 breaths/min or PaCO2 < 32 mmHg or mechanical ventilation)
  • abnormal white blood count (>12,000/cumm or < 4000/cumm)
  • Trauma study patients are adult patients presenting to the rural hospital's EDs with blunt or penetrating injury and one or more of the following criteria:
  • Respiratory insufficiency and/or intubation
  • Glasgow coma scale < 8 with mechanism attributed to trauma
  • Systolic blood pressure of <90mmHg
  • Paralysis
  • Penetrating injury to the head/neck/torso
  • Crush to torso/upper thighs
  • Major amputations
  • Loss of consciousness > 5 minutes
  • Maxillo-facial trauma
  • Significant subcutaneous air
  • Evidence of pelvic instability
  • Two or more long bone deformities
  • Major lacerations involving fascia
  • Ejection from vehicle
  • Pedestrian struck > 15 mph
  • Motorcycle Crash > 25 mph
  • Motor Vehicle Collision > 35 mph
  • Documented falls > 20 feet or 2 stories

Who cannot join

  • The exclusion criteria for septic patients are:
  • -Age < 18 years
  • The exclusion criteria for trauma patients are:
  • Age < 18 years
  • Burn injury of greater than 10% total body surface area
  • Traumatic asphyxiation
  • Lightning strike/electrical shock
  • Patients undergoing cardiopulmonary resuscitation (CPR) on arrival

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • Bamberg County Hospital

    Bamberg, South Carolina, 29003

  • Barnwell County Hospital

    Barnwell, South Carolina, 29812

  • Medical University of South Carolina

    Charleston, South Carolina, 29425

  • Williamsburg Regional Medical Center

    Kingstree, South Carolina, 29556

  • Regional Medical Center of Orangeburg

    Orangeburg, South Carolina, 29118

Other trials in United States

About this study

The care of patients with sepsis and trauma requires the delivery of appropriate definitive care in the early stages of the illness. Hospitals with limited resources, those in rural and underserved areas of South Carolina, may be unable to consistently provide optimal care to these patients. In addition, the shortage of specialists nationally makes it more difficult for these hospitals to recruit and retain the specialists needed. Patients in these areas continue to pay the rural penalty of poorer outcomes. This study provides specialists' level care through telemedicine consults to rural emergency departments in rural areas of SC to improve outcomes for these patients.

The CREST study is a project that specifically addresses the need to bring health care to rural communities in SC, as well as evaluates methods and tests technology to implement this care in rural communities. The CREST study uses telemedicine remotely from MUSC to rural community hospitals to provide rural community physicians care from specialists for trauma and sepsis, which are both high acuity, difficult to treat conditions.

Read more

CREST is a multi-site trial of telemedicine services to meet rural patients' and providers' need for expert evaluation and management of sepsis and trauma. The specific aims of CREST are:

  1. To test the hypothesis that a telemedicine program including education and clinical consultation between a tertiary care academic medical center and rural, local hospitals will significantly improve key treatment decisions and outcome measures in sepsis and trauma.
  2. To test the hypothesis that the differences in ISS and time to antibiotics for trauma and sepsis patients exposed to telemedicine intervention and those without the intervention matched on propensity scores are not due to unmeasured confounders.

CREST seeks new solutions to rural health disparities, to advance technology, create and retain jobs and address important research opportunities by combining implementation of a novel, trans disciplinary clinical program with rigorous, mixed methods scientific evaluation including clinical, process, and economic outcome measures. The impact on both science and quality healthcare outcomes is broad and CREST has far reaching implications for addressing rural health disparities for acute, life-threatening illnesses.

Read the detailed description

The impetus for CREST derives from the observation that rural patients are unlikely to acquire on-site access to appropriate specialist care for high stakes, high acuity, crisis-mode conditions such as sepsis and trauma. Novel, collaborative approaches are necessary to provide rural patients with access to appropriate specialist care for sepsis and trauma. CREST is an innovative, technologically levering mechanism that provides the opportunity to lessen the inferior outcomes and "rural penalty" paid by patients in rural communities.

Rural patients are less likely to have onsite access to specialist care for sepsis and trauma for several reasons:

  • Personnel: there is a nation-wide shortage of appropriate specialty providers including intensivists, trauma surgeons, and other critical care staff 1. Small, rural communities lack the economies of scale to support resource intense services and if a community has these specialties, there is often not around the clock coverage necessary for best quality care for these conditions 1.
  • Physical and material resources: Sepsis and trauma patients require immediate availability of resources such as multidisciplinary ICU staff, large blood banks, operating rooms, and advanced radiological facilities.
  • Availability of resources such as multidisciplinary ICU staff, large blood banks, operating rooms, and advanced radiological facilities.
  • Location and distance: Patients in rural communities have inferior outcomes in sepsis and trauma 2, 3. This is likely multifactorial and includes delays in entry to the Emergency Medical System network, longer travel times to definitive care facilities and delays in definitive care delivery. Inter-hospital transfer may be limited both by severity of patient illness, acute care and ICU bed shortages in tertiary care centers. Additionally, the scarcity of tertiary care hospital beds increases the importance of initiating transfer for patients who will maximally benefit from tertiary care referral 4, 5.

The impact to rural patients with sepsis and trauma, due to lack of access to appropriate specialist care, is substantial. Sepsis is one of the most common serious critical illnesses. It kills 28-50% of patients diagnosed 6, 7 and is the 10th leading cause of death in the US 8. Furthermore, the incidence is increasing in conjunction with the aging of the US population 9. The impact of rurality on sepsis has received modest investigation, but rural patients likely have worse outcomes.3 In SC, patients referred from Emergency Departments (ED's) in smaller, typically rural hospitals have a 22% increase risk of death as compared to those referred from ED's in larger, urban hospitals (CREST preliminary analysis) suggesting the benefits of specialist directed care available to patients at larger facilities. Equally concerning is an apparent race-associated disparity in which African American patients presenting to rural ED's in SC are twice as likely to be discharged from the ED with a diagnosis of sepsis as compared to white patients. Although the rates for discharge from an ED with a diagnosis of sepsis are low at 3.95% for whites and 8.71% for African Americans (CREST preliminary analysis), it is concerning that any patient is discharged from an ED with this diagnosis and the disparate rates may reflect the well-described phenomenon of unequal treatment 10. Critically ill patients with any diagnosis benefit from intensivist-directed care including a 30-40% reduction in mortality.11 Unfortunately, over half of US hospitals have no intensivist coverage at all and rural hospitals are disproportionately affected by this problem 12.

Likewise, trauma is the leading cause of death among Americans up to age 45 and the fourth leading cause of death overall for all ages 8. Deaths from injury occur in a tri-phasic distribution: 50% of deaths from injury occur at the scene, 30% occur in the first 1-2 hours and 20% occur during hospitalization between 1-2 weeks after admission. Trauma care at designated trauma centers improves survival 13. Yet, rural hospitals are rarely trauma centers and in SC patients injured in rural communities have inferior outcomes and higher costs 14. Significant disparities can be identified among SC's elderly and minority populations. 14 An important barrier to facilitating quality care for SC trauma patients relates to triage efficiency between rural hospitals and a trauma center. Outcomes for seriously injured rural patients are negatively affected when patients are taken to non-trauma EDs and then transferred to a trauma center 13 . Conversely, transfer of patients with low risk of death and disability to trauma centers represents over-triage, and creates additional stressors at already busy trauma centers accruing financial burden on the health care system.

CREST is scientifically innovative on multiple levels. It is the first prospective, mixed-methods evaluation of telemedicine; as well as one of the few studies in remote/telemedicine not sponsored by industry. CREST is the first study to demonstrate improved outcomes for sepsis using telemedicine and will augment the sparse literature on trauma and telemedicine. CREST also serves as a demonstration project showing that access to specialist care for rural patients with high stakes, high acuity conditions can be reliably provided through telemedicine. CREST technology is non-proprietary and relatively low cost and thus allows important cost-effectiveness analyses to ascertain the viability of telemedicine in rural settings.

CREST includes two elements - an educational program for rural providers and clinical consultation for patients with sepsis and trauma. Collaborating hospitals receive telemedicine hardware and software, usage instruction, and 24/7 access to MUSC experts in sepsis and trauma for patient consultation in real-time. This project uses a quasi-experimental design, which incorporates a controlled experiment using pre-existing patient groups as the controls. This design minimizes threats to external validity and offers efficiency in the longitudinal aspect of the research. Main dependent measures include time to initiation of appropriate antibiotics for septic patients and reduced transfer rates of less-severe trauma patients as measured by average increase in the Injury Severity Score (ISS). Data collection for the controls in the retrospective groups and the prospective intervention group will be conducted by using structured audit forms by trained staff. The research plan includes investigation of outcomes, including treatment decisions.

Rural hospitals are the primary targets for CREST because these institutions tend to have fewer specialty providers and often cannot provide definitive care for patients with sepsis and trauma. Eligible rural hospitals are strategically identified based on several criteria. First, the hospital is located in a rural area as designated by the US Department of Agriculture. Second, the hospital has substantial resource limitations as indicated by a Level III or IV Medical Facility Status from the Joint Accreditation Committee for Hospital Organizations. Third, the hospital is within MUSC's typical 120 mile catchment area.

CREST investigators are mindful of the importance of collegial and collaborative approaches to recruiting rural hospitals and providers. To establish a framework for the working relationships important to the success of CREST, collaborating hospitals and MUSC sign a Memorandum of Agreement stipulating the roles and expectations. The fundamental duties for the rural hospitals are: 1) work with MUSC research team to facilitate human subjects approval of CREST; 2) coordinate their providers' availability with CREST's educational program; 3) facilitate working relationships between MUSC clinical experts and appropriate clinicians at rural hospitals and 4) allow CREST investigators access to patient records to ascertain outcome measures. MUSC provides: 1) an educational program 2) the technical expertise and equipment; 3) 24/7 availability for clinical evaluations; 4) training and support of chart abstractors to acquire outcome data; and 5) the conducting of analyses and writing of reports for CREST.

CREST allows rural spoke hospitals 24/7 access to MUSC sepsis and trauma experts who provide formal consultation for patients with these conditions including appropriate documentation in the medical record. Rural hospitals can utilize the telemedicine consultants on a one-time basis for initial evaluation and recommendations or request ongoing collaborative care with MUSC clinical experts. If a patient benefits by transfer to MUSC, this is identified and MUSC clinicians are already familiar with the patient's clinical status, representing another advantage of telemedicine services. Alternatively, if patients can be adequately managed at referring spoke sites this is determined, thus improving triage efficiency for tertiary care referrals.

Conditions
Sepsis, Trauma
Medical subject headings
Sepsis, Wounds and Injuries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality

    Measure:

    -Mortality

    Source:

    -Data from the medical record

    Measured: Two Years

Secondary outcomes (2)
  1. Cost Elements

    Measure:

    • Patient charges and cost (before and after telemedicine)
    • Cost of telemedicine
    • Total charges per admission

    Sources:

    • Hospital billing records
    • Staff and consultant time estimates and invoices
    • All-payer hospital discharge data set annual staff salary data

    Measured: Two Years

  2. Provider Acceptance and Satisfaction

    Measure:

    • Provider Experience and Ratings
    • Reports of use, frequency, type
    • Ratings of reliability, expertise, technology
    • Personal efficacy
    • Overall satisfaction

    Sources:

    • Post-project Survey
    • Actual use of the system

    Measured: Two Years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2011 (estimated)
  2. Study startSep 2009
  3. Primary completionMar 2012
  4. Study completionMar 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01426711
Sponsor's protocol ID
CREST-004405-02
Other IDs
RC1MD004405
Acronym
CREST
Status last verified
Apr 2018
First submitted
30 Aug 2011
Last updated
30 Apr 2018
Results posted
No
Data monitoring committee
Yes

Publications

  • Peake SL, Judd N. Supporting rural community-based critical care. Curr Opin Crit Care. 2007 Dec;13(6):720-4. doi: 10.1097/MCC.0b013e3282f1bb21.

    PubMed 17975397
  • Selassie AW, McCarthy ML, Ferguson PL, Tian J, Langlois JA. Risk of posthospitalization mortality among persons with traumatic brain injury, South Carolina 1999-2001. J Head Trauma Rehabil. 2005 May-Jun;20(3):257-69. doi: 10.1097/00001199-200505000-00008.

    PubMed 15908825
  • ARISE; ANZICS APD Management Committee. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand. Crit Care Resusc. 2007 Mar;9(1):8-18.

    PubMed 17352661
  • Seferian EG, Afessa B, Gajic O, Keegan MT, Hubmayr RD; Mayo Epidemiology and Translational Research in Intensive Care. Comparison of community and referral intensive care unit patients in a tertiary medical center: evidence for referral bias in the critically ill. Crit Care Med. 2008 Oct;36(10):2779-86. doi: 10.1097/ccm.0b013e318186ab1b.

    PubMed 18828201
  • Surgenor SD, Corwin HL, Clerico T. Survival of patients transferred to tertiary intensive care from rural community hospitals. Crit Care. 2001;5(2):100-4. doi: 10.1186/cc993. Epub 2000 Feb 1.

    PubMed 11299068
  • Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 8;344(10):699-709. doi: 10.1056/NEJM200103083441001.

    PubMed 11236773
  • Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 8;345(19):1368-77. doi: 10.1056/NEJMoa010307.

    PubMed 11794169
  • National Vital Statistics System - National Center for Health Statistics - CDC. 10 Leading Causes of Death by Age Group - United States. http://www.cdc.gov/ncipc/osp/charts.htm. Accessed Dec. 1, 2008.

  • Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 Jul;29(7):1303-10. doi: 10.1097/00003246-200107000-00002.

    PubMed 11445675
  • Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care; Smedley BD, Stith AY, Nelson AR, editors. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington (DC): National Academies Press (US); 2003. Available from http://www.ncbi.nlm.nih.gov/books/NBK220358/

    PubMed 25032386
  • Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT, Young TL. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA. 2002 Nov 6;288(17):2151-62. doi: 10.1001/jama.288.17.2151.

    PubMed 12413375
  • Angus DC, Shorr AF, White A, Dremsizov TT, Schmitz RJ, Kelley MA; Committee on Manpower for Pulmonary and Critical Care Societies (COMPACCS). Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med. 2006 Apr;34(4):1016-24. doi: 10.1097/01.CCM.0000206105.05626.15.

    PubMed 16505703
  • MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med. 2006 Jan 26;354(4):366-78. doi: 10.1056/NEJMsa052049.

    PubMed 16436768
  • Selassie AW, Pickelsimer EE, Frazier L Jr, Ferguson PL. The effect of insurance status, race, and gender on ED disposition of persons with traumatic brain injury. Am J Emerg Med. 2004 Oct;22(6):465-73. doi: 10.1016/j.ajem.2004.07.024.

    PubMed 15520941

Questions about this trial

What is this clinical trial studying?

An observational study of Sepsis and Trauma, run by Medical University of South Carolina at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 29 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality (time frame: Two Years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01426711, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in